Elderberry Functional Gum and Cognitive & Oral Health in Older Adults
In plain words A study of anthocyanins in people 65 and older, run by Burdur Mehmet Akif Ersoy University. It plans to enroll about 34 people at 1 site, none in the US.
Who it lists and where
Who the trial lists, as registered
Lists people 65 and older. Conditions: Mild Cognitive Impairment (MCI); Aging; Oral Microbiome.
- Individuals aged 60 and over
- Individuals with mildly reduced cognitive function using the MoCA test (MoCA score: 20-25)
- Those with stable systemic diseases (e.g. HT, controlled DM)
- Those with adequate dental health (≥20 natural teeth or no chewing problems with functional prosthesis)
2 more inclusion criteria and the exclusion criteria are on the listing.
What it tests, as registered
Elderberry Anthocyanin Chewing Gum; Placebo Chewing Gum
Registered summary
Globally, the aging population is increasing rapidly, leading to a dramatic rise in the prevalence of Alzheimer's disease and other types of dementia. Neurodegenerative disorders are characterized by pathological hallmarks such as β-amyloid (Aβ) plaque accumulation, tau protein aggregation, synaptic loss, and widespread neuroinflammation. These processes impair key cognitive domains including attention, memory, executive function, and orientation, hindering independent daily functioning. The full summary is on the listing.
Where, as registered
No US site; Turkey (Türkiye) (1).